ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 156 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $751,000 | -9.7% | 59,959 | -0.2% | 0.00% | 0.0% |
| Q3 2016 | $832,000 | +39.8% | 60,094 | -0.2% | 0.00% | 0.0% |
| Q2 2016 | $595,000 | -22.1% | 60,234 | +33.3% | 0.00% | 0.0% |
| Q1 2016 | $764,000 | -22.3% | 45,178 | +2.3% | 0.00% | 0.0% |
| Q4 2015 | $983,000 | -5.0% | 44,173 | +0.6% | 0.00% | 0.0% |
| Q3 2015 | $1,035,000 | -71.6% | 43,888 | -1.5% | 0.00% | -80.0% |
| Q2 2015 | $3,644,000 | +102.1% | 44,571 | +128.9% | 0.01% | +150.0% |
| Q1 2015 | $1,803,000 | +160.5% | 19,468 | +13.8% | 0.00% | +100.0% |
| Q4 2014 | $692,000 | +112.3% | 17,106 | +28.4% | 0.00% | – |
| Q3 2014 | $326,000 | +53.1% | 13,323 | -0.9% | 0.00% | – |
| Q2 2014 | $213,000 | +5.4% | 13,447 | +0.5% | 0.00% | – |
| Q1 2014 | $202,000 | +18.1% | 13,378 | +7.7% | 0.00% | – |
| Q4 2013 | $171,000 | -22.3% | 12,420 | +6.5% | 0.00% | – |
| Q3 2013 | $220,000 | – | 11,664 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |